ACAD
34.71
+0.99
+2.94%
AEMD
2.12
-0.13
-5.78%
APRI
1.16
-0.06
-4.92%
ARNA
1.39
+0.03
+2.21%
ATEC
1.98
+0.02
+1.02%
CNAT
7.52
-0.12
-1.57%
CRXM
0.2
0.00
0.00%
CYTX
1.06
-0.04
-3.64%
DXCM
74.94
+0.05
+0.07%
GNMK
12.855
+0.305
+2.430%
HALO
13.96
+0.57
+4.26%
ILMN
181.5
+1.3
+0.72%
INNV
0.093
-0.002
-2.0000%
INO
6.79
+0.26
+3.98%
ISCO
1.63
-0.02
-1.21%
ISIS
57.56
0.00
0.00%
LGND
108.9
+3.78
+3.60%
LPTN
2.93
0.00
0.00%
MBVX
2.08
+0.07
+3.48%
MEIP
1.56
0.00
0.00%
MNOV
5.57
+0.14
+2.58%
MRTX
4.6
+0.2
+4.55%
MSTX
0.135
-0.003
-2.0275%
NBIX
53.62
+1.84
+3.55%
NUVA
76.94
+0.59
+0.77%
ONCS
1.16
-0.01
-0.8546%
ONVO
2.78
+0.05
+1.83%
OREX
3.1
+0.12
+4.03%
OTIC
13.2
+0.7
+5.60%
QDEL
24.5
+1
+4.26%
RCPT
231.96
0.00
0.00%
RGLS
1.45
+0.05
+3.57%
RMD
70.94
+0.2
+0.28%
SPHS
2.6
-0.01
-0.38%
SRNE
1.9
+0.15
+8.57%
TROV
0.877
-0.003
-0.3070%
VICL
2.36
-0.01
-0.38%
VOLC
18
0.00
0.00%
ZGNX
10.8
+0.2
+1.89%
ACAD
34.71
+0.99
+2.94%
AEMD
2.12
-0.13
-5.78%
APRI
1.16
-0.06
-4.92%
ARNA
1.39
+0.03
+2.21%
ATEC
1.98
+0.02
+1.02%
CNAT
7.52
-0.12
-1.57%
CRXM
0.2
0.00
0.00%
CYTX
1.06
-0.04
-3.64%
DXCM
74.94
+0.05
+0.07%
GNMK
12.855
+0.305
+2.430%
HALO
13.96
+0.57
+4.26%
ILMN
181.5
+1.3
+0.72%
INNV
0.093
-0.002
-2.0000%
INO
6.79
+0.26
+3.98%
ISCO
1.63
-0.02
-1.21%
ISIS
57.56
0.00
0.00%
LGND
108.9
+3.78
+3.60%
LPTN
2.93
0.00
0.00%
MBVX
2.08
+0.07
+3.48%
MEIP
1.56
0.00
0.00%
MNOV
5.57
+0.14
+2.58%
MRTX
4.6
+0.2
+4.55%
MSTX
0.135
-0.003
-2.0275%
NBIX
53.62
+1.84
+3.55%
NUVA
76.94
+0.59
+0.77%
ONCS
1.16
-0.01
-0.8546%
ONVO
2.78
+0.05
+1.83%
OREX
3.1
+0.12
+4.03%
OTIC
13.2
+0.7
+5.60%
QDEL
24.5
+1
+4.26%
RCPT
231.96
0.00
0.00%
RGLS
1.45
+0.05
+3.57%
RMD
70.94
+0.2
+0.28%
SPHS
2.6
-0.01
-0.38%
SRNE
1.9
+0.15
+8.57%
TROV
0.877
-0.003
-0.3070%
VICL
2.36
-0.01
-0.38%
VOLC
18
0.00
0.00%
ZGNX
10.8
+0.2
+1.89%
Home » Archive by Category

Xconomy

Organovo Discloses First Preclinical Data on Human Liver “Patch”

December 13, 2016 – 6:05 am

After taking the first steps toward the development of living human liver tissue “patches” for therapeutic use, San Diego-based Organovo (NASDAQ: ONVO) is laying out its pre-clinical data for the…

[[Click headline to continue reading.]]

San Diego Startup Raises $2.3M to Advance Enzymatic DNA Synthesis

December 12, 2016 – 5:30 am

Molecular Assemblies, a San Diego startup developing a new enzymatic method for synthesizing DNA, said today it has raised $2.3 million in a seed financing round. The funding will be used to hire…

[[Click headline to continue reading.]]

Amyloid Hypothesis Lives On—Solanezumab, Too, Despite “Siren Song”

December 9, 2016 – 11:41 am

When Eli Lilly (NYSE: LLY) reported the day before Thanksgiving, that its Alzheimer’s treatment solanezumab failed to significantly improve the condition of people with a mild form of the…

[[Click headline to continue reading.]]

Bio Roundup: Fast “Cures,” Trump In Time, CRISPR In Court & More

December 9, 2016 – 4:30 am

What a week. The 21st Century Cures Act is now waiting President Obama’s promised signature after easy passage through Congress. President-elect Donald Trump re-stirred the drug-pricing pot…

[[Click headline to continue reading.]]

Craig Venter Used Own Posh Health Clinic To Diagnose His Cancer

December 8, 2016 – 5:17 am

Speaking at a conference in San Francisco Wednesday, geneticist Craig Venter revealed that he had just had surgery for prostate cancer three weeks ago. A health workup at his own high-end clinic,…

[[Click headline to continue reading.]]

Wake Up, Pharma—Trump Is Not Your Savior

December 7, 2016 – 10:01 pm

Since the election, leaders in biotechnology and pharmaceuticals are acting like they got away with robbery. The Nasdaq Biotechnology Index went up 9 percent overnight on November 8th. With Donald…

[[Click headline to continue reading.]]

Senate Approves 21st Century Cures Act, Sending Bill to Obama

December 7, 2016 – 2:32 pm

The U.S. Senate has voted overwhelmingly to approve the 21st Century Cures Act, a wide-ranging healthcare spending and reform bill that aims to infuse medical research with new funding and also speed…

[[Click headline to continue reading.]]

At Late-Night ASH Talk, Juno Execs Look Beyond Stalled “Rocket” Trial

December 6, 2016 – 5:41 am

Juno Therapeutics is still mulling next steps for its lead product, an experimental cancer immunotherapy now stuck in limbo because five of 68 adult leukemia patients in its current study, a clinical…

[[Click headline to continue reading.]]

ASH Roundup: CAR-T Shuffle, Hemophilia Updates, Checkpoint Progress & More

December 6, 2016 – 4:58 am

Two years ago at the American Society of Hematology conference, excitement, not blood, was running in the streets of San Francisco. The cancer immunotherapy known as CAR-T was the star of the show,…

[[Click headline to continue reading.]]

With Nod To Biden, Senate To Say Yes To “Cures” Spending, Reform Bill

December 5, 2016 – 5:31 pm

The U.S. Senate cleared the way for the 21st Century Cures Act, an omnibus healthcare spending and reform bill, by voting 85-13 to end debate this evening. It passed the House with 392 votes last…

[[Click headline to continue reading.]]